More than 580,000 bottles of a blood pressure medication have been recalled due to the presence of potentially harmful chemicals, according to the U.S. Food and Drug Administration (FDA). The recall involves Prazosin Hydrochloride capsules produced by Teva Pharmaceuticals, based in New Jersey. The FDA determined that these capsules contained levels of N-nitroso Prazosin impurity C above acceptable intake limits, which is classified as a known carcinogen.
The recall was first initiated on October 7, 2023, and later classified as a Class II recall on October 24, 2023. A Class II recall indicates that the product may result in temporary or medically reversible adverse health consequences. Although no adverse effects have been reported to date, consumers are urged to verify their medications.
Details of the Recall
The recalled Prazosin Hydrochloride capsules are available in 1 mg, 2 mg, and 5 mg doses and were distributed nationwide. A total of 55 lots of the medication are included in the recall, with specific lot codes provided in the FDA notice. Consumers should check their medicine cabinets for these affected products.
Teva Pharmaceuticals has informed customers about the recall through letters detailing the necessary steps for returning the medication. Affected individuals are encouraged to contact their pharmacies for further guidance on the proper disposal of the recalled capsules.
Next Steps for Consumers
For those in possession of the recalled Prazosin Hydrochloride capsules, it is advisable to reach out to the healthcare provider who prescribed the medication for additional support. Teva has emphasized the importance of consulting with medical professionals regarding any concerns related to the recall.
In light of this situation, consumers are also reminded to check their medicine cabinets for other recalls. Reports indicate multiple recalls in recent months, including over 140,000 bottles of a common statin and various beauty products from Neutrogena. Staying informed about product recalls is essential for ensuring personal health and safety.
For further information, individuals can refer to the FDA’s official website, which provides updates on recalls and safety alerts.
